These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16931883)

  • 1. Cerebrovascular incidents differ in patients with permanent and paroxysmal atrial fibrillation.
    Staszewski J; Staszewska M; Kotowicz J; Brodacki B; Tomczykiewicz K; Stepien A
    Cerebrovasc Dis; 2006; 22(5-6):446-9. PubMed ID: 16931883
    [No Abstract]   [Full Text] [Related]  

  • 2. Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation.
    Pieri A; Lopes TO; Gabbai AA
    Int J Stroke; 2011 Oct; 6(5):466. PubMed ID: 21951414
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment].
    García Escrivà A; López Hernández N; Hernández Lorido R; Oliver Navarrete C; Bustos S; Carneado Ruiz J; Gracia Fleta F; Moltó Jordá JM
    Rev Neurol; 2004 Mar 1-15; 38(5):401-5. PubMed ID: 15029514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study.
    Flaker G; Ezekowitz M; Yusuf S; Wallentin L; Noack H; Brueckmann M; Reilly P; Hohnloser SH; Connolly S
    J Am Coll Cardiol; 2012 Feb; 59(9):854-5. PubMed ID: 22361407
    [No Abstract]   [Full Text] [Related]  

  • 5. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients.
    Poli D; Antonucci E; Marcucci R; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
    Int J Cardiol; 2009 Feb; 132(1):109-13. PubMed ID: 18180057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation type matters: greater infarct volume and worse neurological defects seen in acute cardiogenic cerebral embolism due to persistent or permanent rather than paroxysmal atrial fibrillation.
    Inaba O; Yamauchi Y; Sekigawa M; Miwa N; Yamaguchi J; Nagata Y; Obayashi T; Miyamoto T; Kamata T; Isobe M; Goya M; Hirao K
    Europace; 2018 Oct; 20(10):1591-1597. PubMed ID: 29244081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
    Bishara R; Telman G; Bahouth F; Lessick J; Aronson D
    Thromb Haemost; 2011 Nov; 106(5):877-84. PubMed ID: 21866303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-valvular atrial fibrillation and completed stroke: factors determining mortality, recurrence and prognosis after a first event in the Mexican population].
    Aburto-Murrieta Y; Arauz-Góngora AA; Murillo-Bonilla LM; López-Gómez M
    Rev Neurol; 2005 Mar 1-15; 40(5):269-73. PubMed ID: 15782356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxysmal atrial fibrillation. A common but neglected entity.
    Aboaf AP; Wolf PS
    Arch Intern Med; 1996 Feb; 156(4):362-7. PubMed ID: 8607721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and prevention of ischemic stroke following myocardial infarction: review of current literature.
    Dutta M; Hanna E; Das P; Steinhubl SR
    Cerebrovasc Dis; 2006; 22(5-6):331-9. PubMed ID: 16888371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
    Lip GY
    Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489
    [No Abstract]   [Full Text] [Related]  

  • 13. Everything counts in large amounts: device-detected atrial high-rate arrhythmias.
    Viles-Gonzalez JF; Halperin JL
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):471-3. PubMed ID: 19843913
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation.
    Friberg L; Hammar N; Rosenqvist M
    Eur Heart J; 2010 Apr; 31(8):967-75. PubMed ID: 19176537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basilar artery occlusive disease in the New England Medical Center Posterior Circulation Registry.
    Voetsch B; DeWitt LD; Pessin MS; Caplan LR
    Arch Neurol; 2004 Apr; 61(4):496-504. PubMed ID: 15096396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation.
    Audebert HJ; Schenk B; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2010; 29(5):476-83. PubMed ID: 20299787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustainability and impact of warfarin compliance for atrial fibrillation.
    Kuo S; Burrill J
    Med Health R I; 2007 Dec; 90(12):378-80. PubMed ID: 18314828
    [No Abstract]   [Full Text] [Related]  

  • 18. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of atrial fibrillation among patients with end-stage renal disease.
    Chou CY; Kuo HL; Wang SM; Liu JH; Lin HH; Liu YL; Huang CC
    Nephrol Dial Transplant; 2010 Apr; 25(4):1225-30. PubMed ID: 19923144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.
    Hylek EM; Becker RC
    Ann Neurol; 2008 Nov; 64(5):480-3. PubMed ID: 19067369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.